Resources

Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.

Khemakhem, A.M., Frye, R.E., El-Ansary, A., Al-Ayadhi, L., Bacha, A.B. Metab Brain Dis. 2017; 32(6):1983-1997. Read Articl...

The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder.

Delhey, L.M., Nur Kilinc, E., Yin, L., Slattery, J.C., Tippett, M.L., Rose, S., Bennuri, S.C., Kahler, S.G., Damle, S., Leg...

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Frye, R.E., Rose, S., Slattery, J., MacFabe, D.F. Microb Ecol Health Dis. 2015; 26:27458. Read Article

Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder.

Frye RE. Epilepsy Behav. 2015; 47:147-57. Read Article

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.

Rossignol, D.A., Frye, R.E. Front Physiol. 2014; 22;5:150. Read Article

Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.

Frye, R.E., Melnyk, S., Macfabe, D.F. Transl Psychiatry. 2013; 3:e220. Read Article